1. Home
  2. RM vs NPCE Comparison

RM vs NPCE Comparison

Compare RM & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regional Management Corp.

RM

Regional Management Corp.

HOLD

Current Price

$39.74

Market Cap

356.4M

Sector

Finance

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$16.53

Market Cap

328.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RM
NPCE
Founded
1987
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
356.4M
328.8M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
RM
NPCE
Price
$39.74
$16.53
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$30.00
$17.29
AVG Volume (30 Days)
57.2K
238.2K
Earning Date
11-05-2025
11-04-2025
Dividend Yield
3.19%
N/A
EPS Growth
71.26
N/A
EPS
4.13
N/A
Revenue
$610,145,000.00
$94,864,000.00
Revenue This Year
$16.34
$24.82
Revenue Next Year
$7.05
$1.28
P/E Ratio
$9.10
N/A
Revenue Growth
9.60
24.08
52 Week Low
$25.41
$7.56
52 Week High
$46.00
$18.98

Technical Indicators

Market Signals
Indicator
RM
NPCE
Relative Strength Index (RSI) 60.06 64.81
Support Level $35.99 $16.04
Resistance Level $37.73 $16.94
Average True Range (ATR) 1.48 0.87
MACD 0.25 -0.07
Stochastic Oscillator 93.79 81.22

Price Performance

Historical Comparison
RM
NPCE

About RM Regional Management Corp.

Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.

About NPCE Neuropace Inc.

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Share on Social Networks: